Application 216564
- Type
- NDA
- Sponsor
- DEPROCO
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | FLAVALTA | EPINEPHRINE BITARTRATE; LIDOCAINE HYDROCHLORIDE | SOLUTION;INJECTION | EQ 0.017MG BASE/1.7ML (EQ 0.01MG BASE/ML);34MG/1.7ML (20MG/ML) | Yes | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N216564-001 | FLAVALTA | EPINEPHRINE BITARTRATE; LIDOCAINE HYDROCHLORIDE | EQ 0.017MG BASE/1.7ML (EQ 0.01MG BASE/ML);34MG/1.7ML (20MG/ML) | SOLUTION / INJECTION | RLD, RS | 2026-03-19 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N216564-001 | FLAVALTA | EQ 0.017MG BASE/1.7ML (EQ 0.01MG BASE/ML);34MG/1.7ML (20MG/ML) | SOLUTION / INJECTION | RLD, RS | 2026-03-19 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N216564-001 | FLAVALTA | EQ 0.017MG BASE/1.7ML (EQ 0.01MG BASE/ML);34MG/1.7ML (20MG/ML) | SOLUTION / INJECTION | RLD, RS | 2026-03-19 | caaa826d4ba7… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N216564-001 | FLAVALTA | EQ 0.017MG BASE/1.7ML (EQ 0.01MG BASE/ML);34MG/1.7ML (20MG/ML) | SOLUTION / INJECTION | RLD, RS | 2026-03-19 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Flavalta | LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE | Septodont, Inc. | 3f9f9b4f-bf6c-4b57-ac1a-98fd1a9a369d | 2026-03-31 | Warnings, Adverse reactions | 216564 NDA216564 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Documents#
| Document | Submission type | Date |
|---|---|---|
| 85461 | ORIG | 2026-03-23 |